Eli Lilly and Company’s newly launched oral weight loss drug was prescribed 5,612 times across the United States in its third week following market introduction, according to analysts who cited IQVIA prescription data, News.Az reports, citing Reuters.
The figures indicate early uptake of the drug as it continues to gain traction after its launch, based on pharmacy and prescription tracking information compiled by IQVIA.
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。